Which patient scenario currently requires antibiotic prophylaxis for infective endocarditis?

Which patient scenario currently requires antibiotic prophylaxis for infective endocarditis?

• A. A patient with a repaired congenital defect with no residual shunt
• B. A patient with hypertension
• C. A patient with a prior myocardial infarction
• D. A patient with a prosthetic cardiac valve

Answer: (C)

Antibiotic prophylaxis for infective endocarditis is reserved for a small, high-risk group of cardiac conditions where even brief bacteremia from procedures could seed a damaged valve or prosthetic material. The current guidance limits prophylaxis to patients with prosthetic heart valves, a history of infective endocarditis, certain congenital heart diseases (such as unrepaired cyanotic CHD or repaired CHD with residual defects or with prosthetic material within the first six months after repair), and heart transplant recipients with valvular disease. Applying that to the scenarios: having hypertension or a prior myocardial infarction does not place a person in the high-risk category, so they do not require prophylaxis. A repaired congenital defect with no residual shunt also does not meet the high-risk criteria unless there is prosthetic material or a recent repair within the window where prosthetic material is still present. The scenario with a prosthetic cardiac valve clearly falls into the group that requires prophylaxis because the prosthetic material increases the risk of endocarditis from bacteremia. In practice, when prophylaxis is indicated, it’s given before procedures likely to cause bacteremia (such as many dental procedures), with agents like amoxicillin before the procedure, and alternatives for those with penicillin allergy.

Antibiotic prophylaxis for infective endocarditis is reserved for a small, high-risk group of cardiac conditions where even brief bacteremia from procedures could seed a damaged valve or prosthetic material. The current guidance limits prophylaxis to patients with prosthetic heart valves, a history of infective endocarditis, certain congenital heart diseases (such as unrepaired cyanotic CHD or repaired CHD with residual defects or with prosthetic material within the first six months after repair), and heart transplant recipients with valvular disease.

Applying that to the scenarios: having hypertension or a prior myocardial infarction does not place a person in the high-risk category, so they do not require prophylaxis. A repaired congenital defect with no residual shunt also does not meet the high-risk criteria unless there is prosthetic material or a recent repair within the window where prosthetic material is still present. The scenario with a prosthetic cardiac valve clearly falls into the group that requires prophylaxis because the prosthetic material increases the risk of endocarditis from bacteremia.

In practice, when prophylaxis is indicated, it’s given before procedures likely to cause bacteremia (such as many dental procedures), with agents like amoxicillin before the procedure, and alternatives for those with penicillin allergy.